GMO pig intended for medical use wins feds’ OK

NEW YORK — U.S. regulators approved a genetically modified pig for food and medical products, making it the second such animal to get the green light for human consumption.

But the company behind it said there are no imminent plans to sell it for meat.

The pig is genetically engineered to eliminate the presence of alpha-gal, a type of sugar found in many mammals. The sugar makes its way into many products — including medications, cosmetics and food — and can cause allergic reactions in some people.

The main goal of the company behind the pig, United Therapeutics Corp., is to develop medical products such as blood thinners that won’t set off such reactions, said its spokesman Dewey Steadman.

Eventually, the Silver Spring, Maryland-based firm hopes to develop a way for the pig’s organs to be transplanted into people.

The pig, called Galsafe, also has commercial potential as food, but Steadman said the company doesn’t know when it might be able to secure an agreement with a meat producer to process and sell it. He said the meat allergy the pig addresses, called alpha-gal syndrome, isn’t yet considered a major issue.

“It’s known, but it’s not wellknown,” Steadman said.

Health researchers don’t fully understand how the allergy develops, but it has been tied to bites from certain ticks. In 2009, there were 24 reported cases, but more recent estimates exceed 5,000 cases.

Symptoms can include hives, itching, cramping and vomiting. Unlike other food allergies, alpha-gal reactions typically happen several hours after consumption of beef, pork or lamb, making it difficult to diagnose.

The Food and Drug Administration said it didn’t evaluate allergy-specific food safety, since the company’s application didn’t include data on the prevention of such reactions.